ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

U.S. Cigarette Sales Dropped 4.2 Percent Last Year

March 31, 2006

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999

Elderly Patients Fail To Receive New Cancer Therapy For CML

August 27, 2010

DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported

November 17, 1978

Texas (Galveston) Scores Nine Points Ahead Of RPMI In Organ Systems Competitio; NCAB To Decide Award

May 4, 1984